Want to see IN:QUICKHEAL full AI Analyst Report?
Top Page
Quick Heal Technologies Ltd.
(QUICKHEAL)
Select Model
Select Model
Rating:46Neutral
Price Target:
₹152.00
▼(-1.94% Downside)
Action:Reiterated
Date:06/03/26
The score is mainly held back by weakening fundamentals (declining revenue, swing into losses, and inconsistent cash generation). Technicals also remain soft with the stock below key moving averages, while valuation is difficult to support because the company is loss-making and dividend yield data is unavailable.
Positive Factors
Low Leverage / Strong Balance Sheet
The company’s near-zero debt and substantial equity provide a durable capital buffer. Low leverage preserves financial flexibility to fund R&D, channel expansion or M&A, and absorb downturns without immediate refinancing pressure, supporting long-term strategic options.
Negative Factors
Declining Revenue Trend
Top-line has weakened: revenues fell ~4% in FY2025 and ~6% in FY2026. Persistent revenue declines erode scale advantages, strain channel relationships, and make fixed-cost absorption harder, risking prolonged margin pressure unless growth or retention improves.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage / Strong Balance Sheet
The company’s near-zero debt and substantial equity provide a durable capital buffer. Low leverage preserves financial flexibility to fund R&D, channel expansion or M&A, and absorb downturns without immediate refinancing pressure, supporting long-term strategic options.
Read all positive factors
Quick Heal Technologies Ltd. (QUICKHEAL) vs. iShares MSCI India ETF (INDA)
Market Cap
₹8.32B
Dividend YieldN/A
Average Volume (3M)72.37K
Price to Earnings (P/E)―
Beta (1Y)1.83
Revenue Growth-6.64%
EPS Growth-125.65%
CountryIN
Employees996
SectorGeneral
Sector StrengthN/A
IndustrySoftware - Application
Share Statistics
EPS (TTM)-1.90
Shares Outstanding54,258,503
10 Day Avg. Volume143,023
30 Day Avg. Volume72,369
Financial Highlights & Ratios
PEG Ratio0.20
Price to Book (P/B)1.59
Price to Sales (P/S)2.65
P/FCF Ratio1.69K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Quick Heal Technologies Ltd. Business Overview & Revenue Model
Company Description
Quick Heal Technologies Limited, an Indian company established in Pune in 1995, specializes in providing cybersecurity software and solutions. The firm caters to a diverse clientele, including individual consumers, small and medium-sized businesse...
How the Company Makes Money
Quick Heal primarily makes money by selling cybersecurity software licenses and subscriptions under its consumer (Quick Heal) and enterprise/government (Seqrite) product lines. Revenue is generated through (1) consumer retail and online sales of a...
Quick Heal Technologies Ltd. Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
82
Very Positive
Cash Flow
46
Neutral
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.61B | 2.80B | 2.92B | 2.78B | 3.42B |
| Gross Profit | 599.40M | 2.72B | 1.17B | 1.14B | 1.92B |
| EBITDA | -293.70M | -65.90M | 373.00M | 227.70M | 1.07B |
| Net Income | -109.30M | 50.40M | 242.40M | 64.00M | 831.90M |
Balance Sheet | |||||
| Total Assets | 5.47B | 5.25B | 5.13B | 4.93B | 7.16B |
| Cash, Cash Equivalents and Short-Term Investments | 2.18B | 1.93B | 2.20B | 1.88B | 3.54B |
| Total Debt | 1.10M | 3.10M | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.10B | 835.60M | 756.30M | 735.90M | 882.50M |
| Stockholders Equity | 4.37B | 4.41B | 4.37B | 4.20B | 6.28B |
Cash Flow | |||||
| Free Cash Flow | 4.10M | -367.20M | 106.30M | 267.30M | 741.30M |
| Operating Cash Flow | 158.30M | -223.00M | 181.90M | 308.10M | 799.80M |
| Investing Cash Flow | -261.80M | 159.70M | 61.50M | 1.85B | 1.26B |
| Financing Cash Flow | 27.60M | -103.20M | 16.00M | -2.12B | -2.14B |
Quick Heal Technologies Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ₹6.65B | 17.99 | ― | 5.00% | 15.97% | 16.72% | |
72 Outperform | ₹38.60B | 32.91 | ― | 0.27% | 29.74% | 25.01% | |
62 Neutral | ₹7.47B | 8.49 | ― | ― | 9.34% | 1.11% | |
60 Neutral | ₹6.94B | 24.18 | ― | ― | -2.29% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
46 Neutral | ₹8.32B | -80.46 | ― | ― | -6.64% | -125.65% | |
42 Neutral | ₹601.06M | -0.38 | ― | ― | -62.43% | -1029.62% |
* General Sector Average
IN:QUICKHEAL
Quick Heal Technologies Ltd.
154.10
-130.80
-45.91%
IN:EMUDHRA
eMudhra Limited
538.90
-228.30
-29.76%
IN:KELLTONTEC
Kellton Tech Solutions Ltd.
14.10
-11.67
-45.29%
IN:KSOLVES
Ksolves India Ltd
282.25
-20.87
-6.89%
IN:SECURKLOUD
SecureKloud Technologies Limited
19.60
-4.06
-17.16%
IN:SUBEXLTD
Subex Limited
13.73
1.34
10.82%
Quick Heal Technologies Ltd. Corporate Events
Exchange Seeks Clarification From Quick Heal After Sharp Stock Move
May 11, 2026
The stock of Quick Heal Technologies Limited has shown significant price movement, prompting the exchange to seek updated, relevant information from the company. The exchange’s action underscores a focus on safeguarding investor interests an...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.